(Q42541187)

2 November 2017

title

Serotonin syndrome following the administration of tramadol with paroxetine (English)

1 reference

2 November 2017

0 references

1 reference

Lantz MS

1

1 reference

2 November 2017

Buchalter EN

series ordinal

2

1 reference

2 November 2017

Giambanco V

series ordinal

3

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

International Journal of Geriatric Psychiatry

2 November 2017

published in

1 reference

2 November 2017

volume

13

1 reference

2 November 2017

issue

5

1 reference

2 November 2017

page(s)

343-345

1 reference

Pathophysiology and management of the serotonin syndrome

2 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199805%2913%3A5%3C343%3A%3AAID-GPS771%3E3.0.CO%3B2-5

Possible serotonin syndrome with trazodone addition to fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199805%2913%3A5%3C343%3A%3AAID-GPS771%3E3.0.CO%3B2-5

Serotonin syndrome induced by administration of venlafaxine and phenelzine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199805%2913%3A5%3C343%3A%3AAID-GPS771%3E3.0.CO%3B2-5

Serotonin syndrome and drug combinations: focus on MAOI and RIMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199805%2913%3A5%3C343%3A%3AAID-GPS771%3E3.0.CO%3B2-5

Serotonin syndrome due to venlafaxine and maintenance tranylcypromine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199805%2913%3A5%3C343%3A%3AAID-GPS771%3E3.0.CO%3B2-5

Isolated venlafaxine-induced serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199805%2913%3A5%3C343%3A%3AAID-GPS771%3E3.0.CO%3B2-5

Selective serotonin reuptake inhibitor-induced serotonin syndrome: review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199805%2913%3A5%3C343%3A%3AAID-GPS771%3E3.0.CO%3B2-5

Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199805%2913%3A5%3C343%3A%3AAID-GPS771%3E3.0.CO%3B2-5

Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199805%2913%3A5%3C343%3A%3AAID-GPS771%3E3.0.CO%3B2-5

Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson's disease. Parkinson Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199805%2913%3A5%3C343%3A%3AAID-GPS771%3E3.0.CO%3B2-5

Extreme suicidality following serotonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199805%2913%3A5%3C343%3A%3AAID-GPS771%3E3.0.CO%3B2-5

The serotonin syndrome. Implicated drugs, pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291099-1166%28199805%2913%3A5%3C343%3A%3AAID-GPS771%3E3.0.CO%3B2-5

10.1002/(SICI)1099-1166(199805)13:5<343::AID-GPS771>3.0.CO;2-5

21 January 2018

Identifiers

DOI

1 reference

2 November 2017

1 reference